artenimol has been researched along with Helicobacter Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, C; Chen, S; Ding, X; Guo, Z; Li, C; Mao, R; Peng, C; Wang, Z; Xie, Z; Yan, J; Yang, C; Yang, YY; Yao, M; Yu, J; Yuan, P; Zhang, J | 1 |
| Guan, J; Huang, P; Li, F; Liu, L; Liu, Z; Lu, L; Qi, X; Su, T; Wang, D; Wang, Y | 1 |
2 other study(ies) available for artenimol and Helicobacter Infections
| Article | Year |
|---|---|
Gastric Acid-Responsive ROS Nanogenerators for Effective Treatment of Helicobacter pylori Infection without Disrupting Homeostasis of Intestinal Flora.
Topics: Animals; Gastric Acid; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Mice; Reactive Oxygen Species | 2023 |
Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling.
Topics: Animals; Anticarcinogenic Agents; Artemisinins; Artesunate; Bacterial Adhesion; Cell Line, Tumor; Cytokines; Helicobacter Infections; Helicobacter pylori; Humans; Mice, Inbred C57BL; Microbial Sensitivity Tests; NF-kappa B; Reactive Oxygen Species; Stomach Neoplasms | 2019 |